ATE4197T1 - Peptide, verfahren zur herstellung derselben und diese enthaltende arzneimittel beziehungsweise diagnostica. - Google Patents

Peptide, verfahren zur herstellung derselben und diese enthaltende arzneimittel beziehungsweise diagnostica.

Info

Publication number
ATE4197T1
ATE4197T1 AT81100357T AT81100357T ATE4197T1 AT E4197 T1 ATE4197 T1 AT E4197T1 AT 81100357 T AT81100357 T AT 81100357T AT 81100357 T AT81100357 T AT 81100357T AT E4197 T1 ATE4197 T1 AT E4197T1
Authority
AT
Austria
Prior art keywords
radical
group
nitrogen atom
protective group
atom
Prior art date
Application number
AT81100357T
Other languages
English (en)
Inventor
Olga Dipl.-Chem. Nyeki
Lajos Dr.Dipl.-Chem. Kisfaludy
Egon Dr. Karpati
Laszlo Dr. Szporny
Original Assignee
Richter Gedeon Vegyeszeti Gyar R.T.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszeti Gyar R.T. filed Critical Richter Gedeon Vegyeszeti Gyar R.T.
Application granted granted Critical
Publication of ATE4197T1 publication Critical patent/ATE4197T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/14—Angiotensins: Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Vascular Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT81100357T 1980-01-18 1981-01-19 Peptide, verfahren zur herstellung derselben und diese enthaltende arzneimittel beziehungsweise diagnostica. ATE4197T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU8080100A HU181008B (en) 1980-01-18 1980-01-18 Process for producing angiotenzin-ii analogues of antagonistic activity containing sarcosyl-group at the 1-positon,and an alpha-hydroxy-carboxylic acid at the 8-position
EP81100357A EP0034260B1 (de) 1980-01-18 1981-01-19 Peptide, Verfahren zur Herstellung derselben und diese enthaltende Arzneimittel beziehungsweise Diagnostica

Publications (1)

Publication Number Publication Date
ATE4197T1 true ATE4197T1 (de) 1983-08-15

Family

ID=10947908

Family Applications (1)

Application Number Title Priority Date Filing Date
AT81100357T ATE4197T1 (de) 1980-01-18 1981-01-19 Peptide, verfahren zur herstellung derselben und diese enthaltende arzneimittel beziehungsweise diagnostica.

Country Status (19)

Country Link
US (1) US4330532A (de)
EP (1) EP0034260B1 (de)
JP (1) JPS56142251A (de)
AT (1) ATE4197T1 (de)
AU (1) AU541000B2 (de)
CA (1) CA1149377A (de)
CS (1) CS219939B2 (de)
DE (1) DE3160608D1 (de)
DK (1) DK149777C (de)
ES (1) ES498583A0 (de)
FI (1) FI73225C (de)
HU (1) HU181008B (de)
IL (1) IL61922A (de)
IN (1) IN153279B (de)
NO (1) NO151409C (de)
PH (1) PH17196A (de)
PL (1) PL130448B1 (de)
SU (1) SU993816A3 (de)
YU (1) YU42550B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5182264A (en) * 1986-03-07 1993-01-26 Schering Corporation Angiotensin II receptor blockers as antiglaucoma agents
DE19529604A1 (de) * 1995-08-11 1997-02-13 Bayer Ag Endoparasitizide Mittel auf Basis von Didepsipeptiden, neue Didepsipeptide und ein Verfahren zu ihrer Herstellung
US9572856B2 (en) * 2009-12-16 2017-02-21 The George Washington University a Congressionally Chartered Not-for-Profit Corporation Method of treating low blood pressure
JP6522584B2 (ja) 2013-04-26 2019-05-29 ラ ホヤ ファーマシューティカル カンパニーＬａ Ｊｏｌｌａ Ｐｈａｒｍａｃｅｕｔｉｃａｌ Ｃｏｍｐａｎｙ 腎不全を処置するための組成物及び方法
MX2016008108A (es) 2013-12-18 2017-03-09 The George Washington Univ A Congressional Chartered Not-For-Profit Cororation Angiotensina ii sola o en combinacion para el tratamiento de hipotension.
TW201733610A (zh) 2016-01-07 2017-10-01 拉荷亞製藥公司 投與血管收縮素ｉｉ之方法
US11583568B2 (en) 2017-04-14 2023-02-21 La Jolla Pharma, Llc Methods for administering angiotensin II

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3947575A (en) * 1969-06-30 1976-03-30 E. R. Squibb & Sons, Inc. Peptides as argiotensin converting enzyme inhibitors
DE2323322A1 (de) * 1973-05-09 1974-11-28 Hoechst Ag Neue peptide mit blutdrucksenkender wirkung und verfahren zu ihrer herstellung
US3923770A (en) * 1974-05-10 1975-12-02 Francis Merlin Bumpus {8 Me{hd 2{b Gly{hu 1{b , Ile{hu 8{b {9 -Anziotensin II as an angiotensin antagonist
US3923769A (en) * 1974-05-10 1975-12-02 Francis Merlin Bumpus {8 N-Me-Ile{40 ,Ile{hu 8{b {9 -Angiotensin II as an angiotensin antagonist
US3915948A (en) * 1974-08-05 1975-10-28 Morton Norwich Products Inc Sarcosyl-L-arginyl-L-valyl-L-tyrosyl-L-valyl-L-histidyl-L-proline
DE2457463A1 (de) * 1974-12-05 1976-06-10 Hoechst Ag Neue peptide mit blutdrucksenkender wirkung und verfahren zu ihrer herstellung
US3975365A (en) * 1975-01-27 1976-08-17 G. D. Searle & Co. Inhibitory octapeptides angiotensin II
US3976770A (en) * 1975-02-10 1976-08-24 Francis Merlin Bumpus Sar'-(OMe)Thr8 Angiotensin II as an angiotensin II antagonist
HU177133B (en) * 1977-07-18 1981-07-28 Richter Gedeon Vegyeszet Process for preparing angiotensin ii analogues containing alpha- amino-oxy-acid in position 1 with angiotensin ii antagonist activity
HU177134B (en) * 1977-07-18 1981-07-28 Richter Gedeon Vegyeszet Process for preparing angiotensin ii analogues containing alpha-hydroxy-acid in position 1 with angiotensin ii antagonist activity

Also Published As

Publication number Publication date
CS219939B2 (en) 1983-03-25
PL130448B1 (en) 1984-08-31
NO151409C (no) 1985-04-10
IN153279B (de) 1984-06-23
DE3160608D1 (en) 1983-08-25
CA1149377A (en) 1983-07-05
FI73225B (fi) 1987-05-29
NO810149L (no) 1981-07-20
YU9381A (en) 1983-09-30
DK149777C (da) 1987-04-21
FI810123L (fi) 1981-07-19
EP0034260A1 (de) 1981-08-26
JPS56142251A (en) 1981-11-06
ES8201129A1 (es) 1981-12-01
IL61922A (en) 1984-01-31
PH17196A (en) 1984-06-19
SU993816A3 (ru) 1983-01-30
EP0034260B1 (de) 1983-07-20
FI73225C (fi) 1987-09-10
AU6627681A (en) 1981-07-23
DK20481A (da) 1981-07-19
US4330532A (en) 1982-05-18
ES498583A0 (es) 1981-12-01
AU541000B2 (en) 1984-12-13
DK149777B (da) 1986-09-29
YU42550B (en) 1988-10-31
PL229223A1 (de) 1982-03-01
HU181008B (en) 1983-05-30
NO151409B (no) 1984-12-27
IL61922A0 (en) 1981-02-27

Similar Documents

Publication Publication Date Title
KR860006488A (ko) 펩티다제 억제물의 제조방법
DE3360282D1 (en) Amino acid preparations containing glutaminic residues
ATE46696T1 (de) 1- und 1,1-disubstituierte, 6-substituierte, 2carbamimidoyl-1-carbadethiapen-2-em-3carbons|uren, verfahren zur herstellung und diese enthaltende antibiotische zusammensetzung.
ATE84972T1 (de) Verfahren zur herstellung eines intravenoes anwendbaren und in fluessiger form stabilen immunglobulins.
PT76333A (en) Process for preparing dipeptide sweetener-metal complexes
ATE4197T1 (de) Peptide, verfahren zur herstellung derselben und diese enthaltende arzneimittel beziehungsweise diagnostica.
EP0291804A3 (de) Proteine mit TNF-Wirkung
FI892185A (fi) Menetelmä terapeuttisesti käyttökelpoisten peptidiyhdisteiden valmistamiseksi
KR870002145A (ko) 아미노산 유도체의 제조방법
DK149091C (da) Analogifremgangsmaade til fremstilling af peptider indeholdende 2-7 aminosyrerester, desaminodipeptider eller amider deraf med ubiquitin-lignende aktivitet eller farmaceutisk acceptable syreadditionssalte deraf
ATE87315T1 (de) Immunostimulierende peptide, deren verfahren zur herstellung und sie enthaltende pharmazeutische zusammensetzungen.
Strachan Total synthesis of an enzyme. II. Synthesis of a protected tetratetracontapeptide corresponding to the 21-64 sequence of ribonuclease A
ATE83242T1 (de) Cysteinreiche, gamma-glutaminsaeure und betaalanin-einheitenaufweisende peptide, verfahren zu deren herstellung und ihre verwendung.
Morell et al. Configuration of the. beta.-carbon atoms of the. beta.-methyllanthionine residues in nisin
Anderson et al. [49] Preparation and use of glutathione monoesters
KR890013061A (ko) 폴리펩티드 유도체
IE820292L (en) Process for removing an n-formyl group from dipeptides
DE59813491D1 (de) Verfahren zur Herstellung eines eine Hyaluronidase enthaltenden Präparats
Frankel et al. 82. Syntheses of some polymeric polypeptides of lanthionine
Rodante et al. Thermodynamics of dipeptides. part ii. influence of methyl groups on the α free carboxyl and amino groups. study of a symmetrical system
AU541547B2 (en) Method of using motility increasing peptides
GB986904A (en) Process for the production of peptides
JPS57108053A (en) Tripeptide and its derivative
US3585180A (en) Process for preparing peptides containing histidine protected with a 2,2,2,-trihalogeno - n -benzyloxycarbonylaminoethyl group
Dernst et al. Water‐soluble amino acid derivatives of syndiotactic poly (2‐methylallyl alcohol)